Febbo Phillip G. sold $564K of VCYT
Febbo Phillip G. (Chief Scientific & Med Officer) sold 13,110 shares of VERACYTE, INC. (VCYT) at an average of $43.05 ($42.89–$43.66, $0.56M total) across 2 trades on 2026-09-04 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale is the first public report of this insider's transaction, offering fresh data for traders.
Market read
A mid-sized insider sale provides a modest signal; limited impact unless accompanied by other news.
What to watch
Potential upcoming corporate events or financing needs not disclosed could be driving the sale.
Background
Form 4 filing discloses insider transactions; investors monitor such sales for signals.
Ticker impact
Chief Scientific & Med Officer Phillip G. Febbo sold 13,110 shares for $564K via a 10b5-1 plan on Sep 4, 2026.
Modest downward pressure; price may dip 1-2% if market reacts.
Sale size is modest relative to market cap, but insider status adds weight; no other catalyst present.
Counterpoint
The sale could be a routine liquidity move, not a negative signal; price may remain stable.
Key entities
- CompanyVeracyte, Inc.
Medical diagnostics company listed on NASDAQ under VCYT.
- InsiderPhillip G. Febbo
Chief Scientific & Med Officer at Veracyte.